102 related articles for article (PubMed ID: 11351261)
1. Microsatellite instability correlates with normal expression of cyclin E in hepatocellular carcinomas.
Nozaki I; Ohashi R; Matsubara N; Hirai R; Andou A; Miyazaki M; Shimizu N; Namba M
Int J Oncol; 2001 Jun; 18(6):1265-9. PubMed ID: 11351261
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas.
Ohashi R; Gao C; Miyazaki M; Hamazaki K; Tsuji T; Inoue Y; Uemura T; Hirai R; Shimizu N; Namba M
Anticancer Res; 2001; 21(1B):657-62. PubMed ID: 11299822
[TBL] [Abstract][Full Text] [Related]
3. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
Zhang SH; Cong WM; Xian ZH; Wu MC
World J Gastroenterol; 2005 May; 11(20):3034-9. PubMed ID: 15918185
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal expressions of cyclin E and cyclin D1 in hepatocellular carcinoma.
Jung YJ; Lee KH; Choi DW; Han CJ; Jeong SH; Kim KC; Oh JW; Park TK; Kim CM
Cancer Lett; 2001 Jul; 168(1):57-63. PubMed ID: 11368878
[TBL] [Abstract][Full Text] [Related]
7. Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance.
Zhou Q; He Q; Liang LJ
World J Gastroenterol; 2003 Nov; 9(11):2450-4. PubMed ID: 14606074
[TBL] [Abstract][Full Text] [Related]
8. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
10. Allelic alterations in nontumorous liver tissues and corresponding hepatocellular carcinomas from chinese patients.
Ho MK; Lee JM; Chan CK; Ng IO
Hum Pathol; 2003 Jul; 34(7):699-705. PubMed ID: 12874766
[TBL] [Abstract][Full Text] [Related]
11. Frequent chromosomal instability but no microsatellite instability in hepatocellular carcinomas.
Piao Z; Kim H; Malkhosyan S; Park C
Int J Oncol; 2000 Sep; 17(3):507-12. PubMed ID: 10938391
[TBL] [Abstract][Full Text] [Related]
12. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
[TBL] [Abstract][Full Text] [Related]
13. Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation.
Gross-Goupil M; Riou P; Emile JF; Saffroy R; Azoulay D; Lacherade I; Receveur A; Piatier-Tonneau D; Castaing D; Debuire B; Lemoine A
Int J Cancer; 2003 May; 104(6):745-51. PubMed ID: 12640682
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers.
Chiappini F; Gross-Goupil M; Saffroy R; Azoulay D; Emile JF; Veillhan LA; Delvart V; Chevalier S; Bismuth H; Debuire B; Lemoine A
Carcinogenesis; 2004 Apr; 25(4):541-7. PubMed ID: 14656944
[TBL] [Abstract][Full Text] [Related]
15. Low Levels of Microsatellite Instability at Simple Repeated Sequences Commonly Occur in Human Hepatocellular Carcinoma.
Goumard C; Desbois-Mouthon C; Wendum D; Calmel C; Merabtene F; Scatton O; Praz F
Cancer Genomics Proteomics; 2017; 14(5):329-339. PubMed ID: 28871000
[TBL] [Abstract][Full Text] [Related]
16. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability and p53 mutations in hepatocellular carcinoma.
Karachristos A; Liloglou T; Field JK; Deligiorgi E; Kouskouni E; Spandidos DA
Mol Cell Biol Res Commun; 1999; 2(3):155-61. PubMed ID: 10662591
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability in European hepatocellular carcinoma.
Salvucci M; Lemoine A; Saffroy R; Azoulay D; Lepère B; Gaillard S; Bismuth H; Reynès M; Debuire B
Oncogene; 1999 Jan; 18(1):181-7. PubMed ID: 9926933
[TBL] [Abstract][Full Text] [Related]
19. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
[TBL] [Abstract][Full Text] [Related]
20. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
